Giuseppe Caliendo
Overview
Explore the profile of Giuseppe Caliendo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
798
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Izzo C, Visco V, Cirillo A, Bonadies D, Caliendo G, Rusciano M, et al.
J Cardiovasc Dev Dis
. 2024 Dec;
11(12).
PMID: 39728279
Severe obesity is closely associated with an increased risk of comorbidities and alterations in cardiac structure and function. The primary objective of this study was to investigate cardiovascular (CV) risk...
2.
Andreozzi G, Corvino A, Severino B, Magli E, Perissutti E, Frecentese F, et al.
Pharmaceuticals (Basel)
. 2024 Oct;
17(10).
PMID: 39458961
In recent decades, there has been a startling rise in the number of cancer patients worldwide, which has led to an amazing upsurge in the development of novel anticancer treatment...
3.
Oliveira D, Cardoso V, Britto-Junior J, Fuguhara V, Frecentese F, Sparaco R, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Oct;
PMID: 39382679
The positive chronotropic action induced by 6-nitrodopamine (6-ND) is selectively blocked by β-adrenoceptor antagonists at concentrations that do not affect the positive chronotropic effect induced by dopamine, noradrenaline, and adrenaline....
4.
Miranda D, Cerqueira A, Muscara M, Severino B, Caliendo G, Corvino A, et al.
Eur J Pharm Sci
. 2024 Oct;
203:106925.
PMID: 39374744
Psoriasis is an immune-mediated chronic inflammatory disease that causes major psychosocial impact. Topical corticosteroids represent the standard pharmacological treatment for mild-to-moderate disease, but their local and systemic adverse effects reinforce...
5.
Corvino A, Granato E, Scognamiglio A, Fiorino F, Frecentese F, Magli E, et al.
Molecules
. 2024 Sep;
29(18).
PMID: 39339509
In this study, a new and straightforward process for the preparation of budesonide 21-phosphate (Bud-21P) and its disodium salt (Bud-21P-Na2) is described. The method results in a yield comparable to...
6.
Corvino A, Caliendo G
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39063174
This Special Issue aims to gather new research on hydrogen sulfide (HS)-releasing compounds (Figure 1) as cutting-edge pharmacological tools and to advance the understanding of the critical role that HS...
7.
Corvino A, Caliendo G, Fiorino F, Frecentese F, Valsecchi V, Lombardi G, et al.
ACS Pharmacol Transl Sci
. 2024 Jul;
7(7):1996-2005.
PMID: 39022351
The debilitating neurodegenerative disease known as amyotrophic lateral sclerosis (ALS) is characterized by the progressive loss of motor neurons (MNs) in the brain, spinal cord, and motor cortex. The ALS...
8.
Corvino A, Scognamiglio A, Fiorino F, Perissutti E, Santagada V, Caliendo G, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000122
Among the various drug discovery methods, a very promising modern approach consists in designing multi-target-directed ligands (MTDLs) able to modulate multiple targets of interest, including the pathways where hydrogen sulfide...
9.
Scognamiglio A, Cerqua I, Citi V, Martelli A, Spezzini J, Calderone V, et al.
Eur J Med Chem
. 2024 Jun;
275:116636.
PMID: 38944936
Asthma is a major noncommunicable disease, affecting both children and adults, and represents one of the major causes leading to high health care costs due to the need for chronic...
10.
Secondulfo C, Visco V, Virtuoso N, Fortunato M, Migliarino S, Rispoli A, et al.
Life (Basel)
. 2024 May;
14(5).
PMID: 38792638
Chronic kidney disease (CKD) and cardiovascular disease (CVD) are highly prevalent conditions, each significantly contributing to the global burden of morbidity and mortality. CVD and CKD share a great number...